Radium-223 Dichloride Long-term Follow-up Program

Clinical trial NCT02312960 · COMPLETED

Trial details

NCT number: NCT02312960
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neoplasm Metastasis / Bone and Bones

Start date: 2014-12-18
Primary completion: 2024-01-31
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.